Shi J - Search Results

1

Preparation and Quality Evaluation of Honokiol Nanoparticles Using a New Polysaccharide Polymer as its Carrier.

Weng Y, Zhang H, Xu S, Zhao Y, Ma L, Shi J, Qian K, Liang W, Xiong Y. Weng Y, et al. Among authors: shi j. Curr Drug Deliv. 2023;20(2):183-191. doi: 10.2174/1567201819666220607153457. Curr Drug Deliv. 2023. PMID: 35674293

2

Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy.

Zhang H, Yu J, Ma L, Zhao Y, Xu S, Shi J, Qian K, Gu M, Tan H, Xu L, Liu Y, Mu C, Xiong Y. Zhang H, et al. Among authors: shi j. Int J Pharm. 2022 Aug 25;624:121931. doi: 10.1016/j.ijpharm.2022.121931. Epub 2022 Jun 21. Int J Pharm. 2022. PMID: 35750278

3

Pharmacokinetics of ginkgolide B-lyophilized nanoparticles after intravenous injection in rats using liquid chromatography-tandem mass spectrometry.

Ma L, Zhu L, Peng J, Xu S, Zhao Y, Shi J, Liu Q, Zhang H, Li J, Xiong Y. Ma L, et al. Among authors: shi j. Rapid Commun Mass Spectrom. 2023 Mar 30;37(6):e9465. doi: 10.1002/rcm.9465. Rapid Commun Mass Spectrom. 2023. PMID: 36581608

4

Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOX^Fluc Cells.

Zhao Y, Tang C, Huang J, Zhang H, Shi J, Xu S, Ma L, Peng C, Liu Q, Xiong Y. Zhao Y, et al. Among authors: shi j. ACS Omega. 2023 Jan 23;8(5):4853-4861. doi: 10.1021/acsomega.2c07096. eCollection 2023 Feb 7. ACS Omega. 2023. PMID: 36777569 Free PMC article.

5

Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy.

Zhang H, Chen L, Zhao Y, Luo N, Shi J, Xu S, Ma L, Wang M, Gu M, Mu C, Xiong Y. Zhang H, et al. Among authors: shi j. Asian J Pharm Sci. 2023 Mar;18(2):100796. doi: 10.1016/j.ajps.2023.100796. Epub 2023 Feb 25. Asian J Pharm Sci. 2023. PMID: 37008735 Free PMC article.

6

Delivering Relaxin Plasmid by Polymeric Metformin Lipid Nanoparticles for Liver Fibrosis Treatment.

Li Y, Ma L, Xiong Y, Shi J, Zhang F, Chai Q, Hu G, Liu Y. Li Y, et al. Among authors: shi j. Curr Drug Deliv. 2024;21(3):431-437. doi: 10.2174/1567201820666230407135026. Curr Drug Deliv. 2024. PMID: 37032506

7

Integrated animal experiments and network pharmacology for investigating therapeutic effect of celastrol-loaded liposomes on NAFLD.

Shi J, Ma N, Luo N, Huang J, Xu S, Xiong Y. Shi J, et al. Curr Drug Deliv. 2023 Aug 10. doi: 10.2174/1567201821666230810094643. Online ahead of print. Curr Drug Deliv. 2023. PMID: 37565560

8

Sanhuang Xiexin Decoction Ameliorates TNBC By Modulating JAK2-STAT3 and Lipid Metabolism.

Qi Y, Wu XJ, Shi JB, Shi XW, Zhao N, Xiong Y, Wang LP. Qi Y, et al. Chin J Integr Med. 2024 Dec;30(12):1080-1089. doi: 10.1007/s11655-023-3555-x. Epub 2023 Nov 6. Chin J Integr Med. 2024. PMID: 37930511

9

Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts.

Xu S, Zheng S, Ma N, Zhang H, Shi J, Huang J, Luo N, Wang M, Xiong Y. Xu S, et al. Among authors: shi j. Biochem Pharmacol. 2024 May;223:116139. doi: 10.1016/j.bcp.2024.116139. Epub 2024 Mar 16. Biochem Pharmacol. 2024. PMID: 38499109

10

Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes.

Luo N, Ma L, Ma N, Wei J, Zhang H, Jin W, Li Y, Shi J, Xiong Y. Luo N, et al. Among authors: shi j. Int Immunopharmacol. 2024 Oct 25;140:112759. doi: 10.1016/j.intimp.2024.112759. Epub 2024 Aug 3. Int Immunopharmacol. 2024. PMID: 39098226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,419 results

Search Page

Filters